8 results about "Equisetum hiemale" patented technology

The invention provides a traditional Chinese medicine composition for treating sudden deafness, and relates to the technical field of traditional Chinese medicine pharmacy. The traditional Chinese medicine composition is prepared from 17 traditional Chinese medicinal materials including firethorn fruit, hematoxylon, murraya paniculata, aspongopus, fructus choerospondiatis, lignum dalbergiae odoriferae, ruddle, oyster, borneol, asarum, rhizoma iridis tectori, equisetum, sophora flower, folium turpiniae, medlar, mulberry and hawthorn leaf, and all the medicinal materials are combined to achieve the effects of activating blood and promoting qi circulation, opening orifices and improving hearing, regulating qi and dissipating blood stasis, clearing heat and purging intense heat, nourishing liver and kidney and combining purgation and tonification. When the traditional Chinese medicine composition is used for treating qi stagnation and blood stasis type sudden deafness, the hemodynamics of a patient can be remarkably improved, hearing impairment of the patient can be recovered, clinical symptoms of the patient can be improved, the clinical curative effect can be effectively improved, and the traditional Chinese medicine composition has high safety.

The invention discloses a traditional Chinese medicine tincture for treating verruca plana and verruca filiformis. The traditional Chinese medicine tincture is prepared from the following raw materials in parts by weight: 1 part of cicada slough, 2 parts of horsetail, 3 parts of radix stemonae, 3 parts of fructus xanthii and 60 parts of 75% alcohol. The ointment is externally applied to treat flat warts and filiform warts, has no side effect, is easy to operate by patients, and is not easy to relapse clinically.

This invention discloses a species of *Mucor* and its applications, wherein the *Mucor* ( Mucor moelleri The strain number, JSAFC 2483, was deposited on May 6, 2025, at the China General Microbiological Culture Collection Center (CGMCC), with accession number CGMCC No. 41980. The biocontrol bacteria provided by this invention... Mucor moelleri JSAFC 2483 can effectively inhibit Fusarium equisetifolium ( Fusarium equiseti The growth of *Fusarium equisetifolium* was inhibited by 54.90% in plate confrontation culture, and its secreted extracellular metabolites also significantly reduced the growth of *Fusarium equisetifolium*. When the concentration of JSAFC 2483 extracellular metabolites was 10 mL / 100 mL, it significantly reduced the growth of *Fusarium equisetifolium*. F. equiseti The inhibition rate reached 53.98%. When the extracellular metabolite concentration of JSAFC 2483 was 100 mL / 100 mL, it had a significant inhibitory effect on... F. equiseti The inhibition rate reached 56.64%. At the same time, it promoted the growth of pepper plants.

The application discloses a bacterium Pseudomonas canavaninivorans for preventing and treating diseases and promoting growth of Chinese rose, and application thereof. The bacterium has been preserved in the China General Microbiological Culture Collection Center, and has a preservation number of CGMCC No. 30656 and a classification name of Pseudomonas canavaninivorans. The bacterium is gram-negative, can produce protease, cellulase and siderophore, can dissolve phosphorus and fix nitrogen, and can resist salt and various heavy metal stresses. The bacterium can inhibit growth of Cylindrocarpon destructans, and can antagonize growth of other plant pathogens Botrytis cinerea, Colletotrichum gloeosporioides, Fusarium oxysporum and F. equiseti, has a wide antibacterial spectrum, and can be applied in a wide range. The bacterium can prevent and treat Chinese rose black spot and powdery mildew, and can promote growth of Chinese rose. The application provides a fine biocontrol strain for preventing and treating diseases of Chinese rose and promoting growth of Chinese rose, and has important significance for green prevention and control technology of diseases of Chinese rose and sustainable development of the Chinese rose industry.

The invention discloses a preparation method of a traditional Chinese medicine external liniment for treating viral warts, and relates to the technical field of traditional Chinese medicine external preparations, and the preparation method sequentially comprises the following steps: raw material pretreatment: respectively taking seven medicinal materials including horsetail, prepared cantharides, cyperus rotundus, prepared arisaema consanguineum schott, raw rhubarb, angelica dahurica and wild agastache rugosus, washing, and drying at 50-65 DEG C until the moisture content is less than or equal to 10% to obtain dried medicinal materials; the formula aims at the pathogenesis of heat toxin accumulation and qi and blood stasis of virus warts, the compatibility of monarch, minister, assistant and guide is rigorous, the core medicines such as the processed cantharides and the raw rhubarb have the effects of directly corroding warts and inhibiting viruses, and the alkalization auxiliary materials are combined, so that the medicine can more effectively act on wart tissues with abnormal hyperplasia, and the effect of treating the warts is achieved. The process route of low-temperature drying, co-crushing, alkalization and long-time cold soaking is adopted, the damage of high-temperature decoction to effective components (especially cantharidin and the like) is avoided, the efficient and sufficient extraction of the active components is realized through long-time soaking and alkalization environment, and the stability of the efficacy of the preparation is ensured.

This invention belongs to the field of traditional Chinese medicine composition technology, specifically relating to a topical filamentous growth care composition, its formulation, and a method for preparing the active traditional Chinese medicine extract. The topical filamentous growth care composition includes the following raw materials: Cyperus rotundus, Equisetum hyemale, and Sandalwood. These three traditional Chinese medicines work synergistically to effectively soften and disperse nodules, soothe skin lesions, and improve local abnormal keratinization. This invention also provides a method for preparing the active traditional Chinese medicine extract of this composition, employing a segmented extraction process. First, Cyperus rotundus and Equisetum hyemale are boiled in water and simmered at a constant temperature. After cooling, Sandalwood is added and the mixture is sealed and simmered at a constant temperature. Then, the extract is concentrated under low temperature and reduced pressure to obtain the active extract. This method maximizes the retention of the effective components of each raw material and reduces external irritation. The traditional Chinese medicine composition of this invention is scientifically formulated, mild, safe, and suitable for long-term care of thin and delicate epidermis. It can effectively improve the symptoms of filamentous growths, reduce the recurrence rate, meets the requirements of industrial production, and has good prospects for industrial application.

The invention provides an anti-aging traditional Chinese medicine composition and application thereof in health-care products, and relates to the technical field of traditional Chinese medicine, the traditional Chinese medicine composition is prepared from fructus piperis longi, fingered citron, gordon euryale seed, ginseng, prepared rehmannia root, horsetail, emblic leafflower fruit, polygala tenuifolia, medlar, white hyacinth bean, bunge cherry seed, allium macrostemon and fermented soybean. The traditional Chinese medicine composition plays an anti-aging role through a multi-target and multi-channel comprehensive regulation mechanism, and can effectively improve the cell activity under oxidative stress, improve the cell collagen metabolism imbalance, reduce the positive rate of beta-galactosidase and delay the cell aging process. Meanwhile, the traditional Chinese medicine composition disclosed by the invention can be used for remarkably enhancing the antioxidant capacity of mice, regulating systemic inflammation imbalance and activating telomerase activity of skin tissues, and can also be used for improving glucose and lipid metabolism disorder caused by high-glucose and high-fat diet, so that experimental evidence is provided for developing health care products with multiple effects of resisting ageing, resisting inflammation, improving metabolism and the like; good application prospects are shown in the anti-aging field.

The invention belongs to the technical field of medicines, and particularly relates to a traditional Chinese medicine composition for treating dry eyes as well as a preparation method and application thereof. The traditional Chinese medicine composition is prepared from, by weight, 12-18 parts of fructus lycii, 8-12 parts of flos chrysanthemi, 12-18 parts of radix rehmanniae praeparata, 8-12 parts of wine-prepared fructus corni, 8-12 parts of cortex moutan, 8-12 parts of rhizoma dioscoreae, 8-12 parts of poria cocos, 8-12 parts of rhizoma alismatis, 8-12 parts of flos buddlejae, 8-12 parts of herba equiseti hiemalis and 12-18 parts of radix scrophulariae. The traditional Chinese medicine composition disclosed by the invention has the effect which is statistically obviously superior to that of an existing classic contrast medicine 'wolfberry-chrysanthemum-rehmannia pill' on key indexes which directly reflect the curative effect, such as increasing the tear secretion amount, prolonging the tear film rupture time, reducing the corneal injury score and the like. The invention proves that a synergistic interaction effect is generated by performing targeted medicine taste increase and decrease and proportion optimization on a classical prescription, and the technical problems that the pertinence is not strong and the curative effect is not optimal in the existing technical scheme are solved.